What is the recommended treatment for urinary tract infections (UTIs) in pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Urinary Tract Infections in Pregnancy

For pregnant women with UTIs, first-line treatment should be nitrofurantoin, fosfomycin trometamol, or cephalosporins (particularly cefixime) for 5-7 days, with treatment guided by urine culture results. 1

Diagnosis and Screening

  • A urine culture should be performed in all pregnant women with UTI symptoms to confirm diagnosis and guide appropriate antibiotic selection 1
  • Pregnant women should be screened for and treated for asymptomatic bacteriuria, as this is considered a complicated UTI during pregnancy 2
  • UTIs occur in approximately 5-7% of pregnant women and require prompt treatment to prevent complications for both mother and fetus 3

First-Line Treatment Options

  • Nitrofurantoin (100 mg twice daily for 5 days) is safe and effective in pregnancy but should be avoided in the last trimester due to risk of hemolytic anemia in the newborn 1, 2
  • Fosfomycin trometamol (3g single dose) offers convenient administration and comparable efficacy to multi-day regimens 1, 4
  • Cephalosporins, particularly cefixime, are excellent options when resistance to other agents is suspected or for more severe infections 1, 3

Treatment Duration and Approach

  • Standard treatment duration for symptomatic UTIs in pregnancy is 5-7 days 1
  • Shorter courses (1-3 days) are generally not recommended for pregnant women, except for fosfomycin which is effective as a single dose 1, 4
  • Follow-up urine cultures should be performed 7 days after completing therapy to confirm cure 5

Medications to Avoid During Pregnancy

  • Trimethoprim-sulfamethoxazole should be avoided in the first trimester (potential teratogenic effects) and third trimester (risk of neonatal hyperbilirubinemia) 1, 2
  • Fluoroquinolones are contraindicated throughout pregnancy 1

Management of Recurrent UTIs in Pregnancy

  • For pregnant women with history of recurrent UTIs, post-coital prophylaxis with a single dose of cephalexin (250 mg) or nitrofurantoin (50 mg) is highly effective 6
  • Daily low-dose antibiotic prophylaxis can be considered for frequent recurrences 1

Special Considerations

  • Pregnancy is classified as a complicating factor for UTIs, requiring more careful management 2
  • Outpatient treatment is appropriate for uncomplicated UTIs, while more severe cases may require hospitalization and parenteral antibiotics 3, 7
  • Even asymptomatic bacteriuria requires treatment during pregnancy, unlike in non-pregnant women 1

Common Pitfalls to Avoid

  • Failing to obtain a urine culture before initiating treatment in pregnant women 1
  • Using antibiotics that don't achieve adequate urinary concentrations 1
  • Not following up with repeat urine cultures to confirm cure after treatment 5
  • Using fluoroquinolones or trimethoprim-sulfamethoxazole inappropriately during pregnancy 1, 2

References

Guideline

Treatment of Urinary Tract Infections in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Recommended treatment for urinary tract infection in pregnancy.

The Annals of pharmacotherapy, 1994

Research

Effective prophylaxis for recurrent urinary tract infections during pregnancy.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1992

Research

Treatments for symptomatic urinary tract infections during pregnancy.

The Cochrane database of systematic reviews, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.